| Name | Title | Contact Details |
|---|---|---|
Rahul Kulkarni |
Associate Vice President at Enterprise Marketing & Customer Experience at Indegene | Profile |
Avijit Dutta |
AVP - Enterprise Marketing and Customer Experience | Profile |
Jason Sperber |
AVP Client Partner, Growth Accounts | Profile |
Vishal Shah |
Vice President of Leadership and Organisation Development | Profile |
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products: its lead development program, IMU-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH and exhibits a host-based antiviral effect, is currently being developed as a treatment option for multiple sclerosis, ulcerative colitis, Crohn`s disease, and primary sclerosing cholangitis. IMU-935, a selective inverse agonist of the transcription factor RORγt, is targeted for development in psoriasis and Guillain-Barré syndrome. IMU-856, which targets the restoration of the intestinal barrier function, is targeted for development in diseases involving bowel barrier dysfunction.
Direct Pharmacy Service is a Lanham, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cincinnati Comprehensive Mental Health Agency helping people through many services and a staff of more than 500 highly skilled professionals.
Cytheris is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Envivo is a Watertown, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.